2-Jul-2026
Globe Newswire (Tue, 30-Jun 4:05 PM ET)
Morgan Stanley Keeps Their Hold Rating on 4D Molecular Therapeutics (FDMT)
TipRanks (Tue, 30-Jun 6:36 AM ET)
TipRanks (Tue, 30-Jun 6:15 AM ET)
4D Molecular Therapeutics Secures $200 Million Loan Facility
TipRanks (Mon, 29-Jun 8:30 AM ET)
4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital
Globe Newswire (Mon, 29-Jun 8:00 AM ET)
4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD
Globe Newswire (Mon, 29-Jun 8:00 AM ET)
Globe Newswire (Fri, 26-Jun 7:30 AM ET)
4DMT Announces New Employment Inducement Grants
Globe Newswire (Fri, 12-Jun 4:05 PM ET)
4DMT to Participate in Upcoming Investor Conferences
Globe Newswire (Wed, 27-May 8:00 AM ET)
Globe Newswire (Thu, 7-May 4:05 PM ET)
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
4D Molecular Therapeutics trades on the NASDAQ stock market under the symbol FDMT.
As of July 2, 2026, FDMT stock price climbed to $13.00 with 968,570 million shares trading.
FDMT has a beta of 0.10, meaning it tends to be less sensitive to market movements. FDMT has a correlation of 0.00 to the broad based SPY ETF.
FDMT has a market cap of $679.57 million. This is considered a Small Cap stock.
Last quarter 4D Molecular Therapeutics reported $3 million in Revenue and -$1.01 earnings per share. This beat revenue expectation by $223,000 and missed earnings estimates by -$.02.
In the last 3 years, FDMT traded as high as $36.25 and as low as $2.24.
The top ETF exchange traded funds that FDMT belongs to (by Net Assets): XBI, VTI, IWM, IWN, VXF.
FDMT has outperformed the market in the last year with a price return of +201.6% while the SPY ETF gained +21.3%. FDMT has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +37.1% and +34.6%, respectively, while the SPY returned +13.9% and -0.3%, respectively.
FDMT support price is $11.90 and resistance is $13.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FDMT shares will trade within this expected range on the day.